Novartis AG (NVS) Free Cash Flow by Year
Novartis AG generated $17.6B in free cash flow in fiscal year 2025. This represents an increase of 8.3% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Novartis AG has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NVS Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NVS Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Novartis AG financials
Frequently Asked Questions
What was Novartis AG's free cash flow in fiscal year 2025?
Novartis AG generated $17.6B in free cash flow in fiscal year 2025.
How fast is Novartis AG's free cash flow growing?
Novartis AG (NVS) free cash flow rose by 8.3% year over year, from $16.3B to $17.6B in fiscal year 2025.
How has Novartis AG's free cash flow changed over the years?
Across the 11 fiscal years this page covers, Novartis AG (NVS) free cash flow went from $9.5B in fiscal year 2015 to $17.6B in fiscal year 2025.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Novartis AG (NVS) reported on that line in every period on record.